Photon-counting detector computed tomography compared with cardiac magnetic resonance imaging for myocardial extracellular volume quantification in spontaneous coronary artery dissection
Spontaneous coronary artery dissection (SCAD) may cause myocardial infarction. Photon-counting detector computed tomography (PCD-CT) with late iodine enhancement (LIE) imaging enables myocardial extracellular volume (ECV) quantification. In this single-center, prospective study, we quantified myocardial ECV in patients with SCAD using LIE PCD-CT (n = 20 patients), and compared results with CMR (n = 13 patients). Global ECV<sub>CT</sub> was quantified in the entire myocardium; lesion ECV<sub>CT</sub> was quantified using a threshold-based approach with lesions exceeding an ECV<sub>CT</sub> of 40%. Relative lesion volume was calculated as the proportion of lesion to total myocardial volume. Global ECV<sub>CMR</sub> was calculated across all myocardial segments, lesion ECV<sub>CMR</sub> was derived from manual segmentation. In the 20 patients, lesion ECV<sub>CT</sub> was 45.2% (IQR 44.2-46.8%) compared to a global ECV<sub>CT</sub> of 28.5 ± 5.3%. Relative lesion volume strongly correlated with global ECV<sub>CT</sub> (ρ = 0.938, P < 0.001). A global ECV<sub>CT</sub> cut-off of 28.5% predicted relative lesion volumes < 5% with an AUC of 0.956 (95% CI 0.752-0.999) and a PPV of 82%. Global ECV<sub>CT</sub> (28.0 ± 5.2%) and global ECV<sub>CMR</sub> (29.3 ± 4.2%) was similar (P = 0.085, mean difference 1.4%, 95% limits of agreement: - 4.2 to 7.0%). Lesion ECV<sub>CT</sub> (45.2%, IQR 44.6-46.8) and lesion ECV<sub>CMR</sub> (45.0%, IQR 39.4-48.6) was similar (P = 0.340). In conclusion, LIE PCD-CT enables quantitative myocardial ECV assessment in SCAD patients, showing a good agreement with CMR.
Authors
- Christian Templin (ORCID: https://orcid.org/0000-0003-0287-4193)
- Matthias Eberhard (ORCID: https://orcid.org/0000-0002-9476-3759)
- Jelena-R. Ghadri
- Konstantin Klambauer (ORCID: https://orcid.org/0000-0002-4114-2043)
- Robert Manka (ORCID: https://orcid.org/0000-0002-3383-4998)
- Alexander Gotschy (ORCID: https://orcid.org/0000-0001-8655-3244)
- Tristan T. Demmert
- Davide Di Vece (ORCID: https://orcid.org/0009-0006-4116-3596)
- Victor Schweiger (ORCID: https://orcid.org/0009-0008-9361-8817)
- Ernst Klotz (ORCID: https://orcid.org/0000-0001-9034-2351)
- Hatem Alkadhi (ORCID: https://orcid.org/0000-0002-2581-2166)
- Victor Mergen (ORCID: https://orcid.org/0000-0003-4544-4804)
- Martin F. Reiner (ORCID: https://orcid.org/0000-0002-9887-2469)
- Verena Wilzeck (ORCID: https://orcid.org/0000-0001-7381-8784)
- Michael Würdinger (ORCID: https://orcid.org/0000-0002-3048-0901)
- Andrea Biondo (ORCID: https://orcid.org/0000-0002-8625-1489)
- Lukas J. Moser
Institutions
- University of Zurich (CH)
- Universitätsmedizin Greifswald (DE)
- ETH Zurich (CH)
- Institute for Biomedical Engineering (CH)
- University Hospital of Zurich (CH)
- Siemens Healthineers (Germany) (DE)
Publication Details
- Journal
- Scientific Reports
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1038/s41598-025-23777-3
- Primary Topic
- Cardiovascular Issues in Pregnancy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- AstraZeneca
- Bayer
- Boston Scientific Corporation
- Novo Nordisk
- Schweizerische Herzstiftung
- Universitätsspital Zürich
- Siemens Healthineers
- MicroPort
- Abbott Vascular